A phase I study of imexon plus gemcitabine as first-line...

A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

Steven J. Cohen, Mark M. Zalupski, Manuel R. Modiano, Paul Conkling, Yehuda Z. Patt, Peg Davis, Robert T. Dorr, Michelle L. Boytim, Evan M. Hersh
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
66
Language:
english
Pages:
8
DOI:
10.1007/s00280-009-1162-y
Date:
July, 2010
File:
PDF, 275 KB
english, 2010
Conversion to is in progress
Conversion to is failed